The findings indicate that the currently approved 600-mg dose of intravenous ocrelizumab is optimal to significantly slow ...

Voters will have multiple candidates to choose from for mayor and other offices in most South Mississippi cities, while other candidates are running unopposed in the April 1 municipal primary ...